253 related articles for article (PubMed ID: 17244360)
21. Biology and clinical implications of CD133(+) liver cancer stem cells.
Ma S
Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
He S; Zhang DC; Wei C
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
[TBL] [Abstract][Full Text] [Related]
23. Emerging evidence of molecular biomarkers in hepatocellular carcinoma.
Umeda S; Kanda M; Kodera Y
Histol Histopathol; 2018 Apr; 33(4):343-355. PubMed ID: 28959824
[TBL] [Abstract][Full Text] [Related]
24. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF
Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723
[TBL] [Abstract][Full Text] [Related]
25. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
Masuda T; Miyoshi E
Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
27. Screening and detection of hepatocellular carcinoma.
Simpson HN; McGuire BM
Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
[TBL] [Abstract][Full Text] [Related]
28. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
[TBL] [Abstract][Full Text] [Related]
29. Macrophage profile in primary versus secondary liver tumors.
Avădănei ER; Wierzbicki PM; Giuşcă SE; Grigoraş A; Amălinei C; Căruntu ID
Folia Histochem Cytobiol; 2014; 52(2):112-23. PubMed ID: 25007179
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
Marquardt JU; Galle PR; Teufel A
J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma--an update.
Sinha SN
P N G Med J; 1985 Jun; 28(2):83-8. PubMed ID: 2417429
[TBL] [Abstract][Full Text] [Related]
32. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
Chen Y; Huang A; Gao M; Yan Y; Zhang W
Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
[TBL] [Abstract][Full Text] [Related]
33. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of hepatocellular carcinoma.
El-Serag HB; Marrero JA; Rudolph L; Reddy KR
Gastroenterology; 2008 May; 134(6):1752-63. PubMed ID: 18471552
[TBL] [Abstract][Full Text] [Related]
35. Tumour markers of hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 1989; 4(4):373-84. PubMed ID: 2562350
[No Abstract] [Full Text] [Related]
36. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Montagnana M; Danese E; Lippi G
Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
[TBL] [Abstract][Full Text] [Related]
37. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
38. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].
Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
Kudo M
Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
[TBL] [Abstract][Full Text] [Related]
40. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
Terris B; Cavard C; Perret C
J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
